Annual Total Liabilities
$6.54 M
+$2.78 M+73.89%
December 31, 2023
Summary
- As of February 7, 2025, CHRO annual total liabilities is $6.54 million, with the most recent change of +$2.78 million (+73.89%) on December 31, 2023.
- During the last 3 years, CHRO annual total liabilities has risen by +$2.89 million (+79.21%).
- CHRO annual total liabilities is now at all-time high.
Performance
CHRO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$3.57 M
+$781.26 K+28.04%
September 30, 2024
Summary
- As of February 7, 2025, CHRO quarterly total liabilities is $3.57 million, with the most recent change of +$781.26 thousand (+28.04%) on September 30, 2024.
- Over the past year, CHRO quarterly total liabilities has dropped by -$2.97 million (-45.46%).
- CHRO quarterly total liabilities is now -45.46% below its all-time high of $6.54 million, reached on December 31, 2023.
Performance
CHRO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CHRO Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +73.9% | -45.5% |
| 3 y3 years | +79.2% | +12.2% |
| 5 y5 years | +79.2% | +12.2% |
CHRO Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +77.7% | -45.5% | +28.0% |
| 5 y | 5-year | at high | +79.2% | -45.5% | +28.0% |
| alltime | all time | at high | +79.2% | -45.5% | +28.0% |
Chromocell Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.57 M(+28.0%) |
| Jun 2024 | - | $2.79 M(-4.0%) |
| Mar 2024 | - | $2.90 M(-55.6%) |
| Dec 2023 | $6.54 M | $6.54 M(+10.4%) |
| Sep 2023 | - | $5.93 M(+19.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $4.98 M(+12.0%) |
| Mar 2023 | - | $4.45 M(+18.3%) |
| Dec 2022 | $3.76 M(+2.2%) | $3.76 M(+18.3%) |
| Sep 2022 | - | $3.18 M(-13.6%) |
| Dec 2021 | $3.68 M(+0.8%) | $3.68 M |
| Dec 2020 | $3.65 M | - |
FAQ
- What is Chromocell Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Chromocell Therapeutics?
- What is Chromocell Therapeutics annual total liabilities year-on-year change?
- What is Chromocell Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Chromocell Therapeutics?
- What is Chromocell Therapeutics quarterly total liabilities year-on-year change?
What is Chromocell Therapeutics annual total liabilities?
The current annual total liabilities of CHRO is $6.54 M
What is the all time high annual total liabilities for Chromocell Therapeutics?
Chromocell Therapeutics all-time high annual total liabilities is $6.54 M
What is Chromocell Therapeutics annual total liabilities year-on-year change?
Over the past year, CHRO annual total liabilities has changed by +$2.78 M (+73.89%)
What is Chromocell Therapeutics quarterly total liabilities?
The current quarterly total liabilities of CHRO is $3.57 M
What is the all time high quarterly total liabilities for Chromocell Therapeutics?
Chromocell Therapeutics all-time high quarterly total liabilities is $6.54 M
What is Chromocell Therapeutics quarterly total liabilities year-on-year change?
Over the past year, CHRO quarterly total liabilities has changed by -$2.97 M (-45.46%)